{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:05:46Z","timestamp":1786997146680,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.steroids.2011.02.043","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T17:11:59Z","timestamp":1299517919000},"page":"607-615","source":"Crossref","is-referenced-by-count":76,"title":["Selectivity and potency of the retroprogesterone dydrogesterone in vitro"],"prefix":"10.1016","volume":"76","author":[{"given":"Tea Lani\u0161nik","family":"Ri\u017ener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Bro\u017ei\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Doucette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Turek-Etienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"M\u00fcller-Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Sonneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"B\u00f6cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Husen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2011.02.043_bib0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/09513590701584816","article-title":"Progestogen effects on various organs and their function","volume":"23S","author":"Schindler","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.steroids.2011.02.043_bib0010","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1517\/14656560902851403","article-title":"The use of progesterone and other progestational agents to prevent spontaneous preterm labour and preterm birth","volume":"10","author":"Jayasooriya","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.steroids.2011.02.043_bib0015","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.maturitas.2009.09.013","article-title":"Use of dydrogesterone in hormone replacement therapy","volume":"65S","author":"Mueck","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.steroids.2011.02.043_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/S0015-0282(16)56991-X","article-title":"A randomized, double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis","volume":"62","author":"Overton","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2011.02.043_bib0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/09513590701669583","article-title":"Effective post-laparoscopic treatment of endometriosis with dydrogesterone","volume":"23S1","author":"Trivedi","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.steroids.2011.02.043_bib0030","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.maturitas.2009.11.011","article-title":"The place of dydrogesterone in the treatment of endometriosis and adenomyosis","volume":"65S","author":"Schweppe","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.steroids.2011.02.043_bib0035","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.maturitas.2009.10.011","article-title":"Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium","volume":"65S","author":"Schindler","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.steroids.2011.02.043_bib0040","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jsbmb.2005.08.009","article-title":"The role of dydrogesterone in recurrent (habitual) abortion","volume":"97","author":"Gruber","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2011.02.043_bib0045","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jsbmb.2005.08.013","article-title":"Dydrogesterone in threatened abortion: pregnancy outcome","volume":"97","author":"Omar","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2011.02.043_bib0050","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archpedi.159.10.957","article-title":"Maternal progestin intake and risk of hypospadias","volume":"159","author":"Carmichael","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.steroids.2011.02.043_bib0055","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.earlhumdev.2008.12.016","article-title":"Dydrogesterone use during pregnancy: overview of birth defects reported since 1977","volume":"85","author":"Queisser-Luft","year":"2009","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.steroids.2011.02.043_bib0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/186168a0","article-title":"A new class of hormonally active steroids","volume":"186","author":"Reerink","year":"1960","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2011.02.043_bib0065","first-page":"585","article-title":"6-Dehydro-retroprogesterone (Duphaston), an interesting progesterone-like compound","volume":"9","author":"Aydar","year":"1964","journal-title":"Int J Fertil"},{"key":"10.1016\/j.steroids.2011.02.043_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0039-128X(66)90131-0","article-title":"Some studies of the endocrine properties of dydrogesterone","volume":"7","author":"Boris","year":"1966","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2011.02.043_bib0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF03189462","article-title":"Dydrogesterone: metabolism in man","volume":"5","author":"Van Amsterdam","year":"1980","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.steroids.2011.02.043_bib0080","first-page":"167","article-title":"Dydrogesterone has no peripheral anti-androgenic properties","volume":"1","author":"Vermorken","year":"1987","journal-title":"In vivo"},{"key":"10.1016\/j.steroids.2011.02.043_bib0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/toxsci\/kfi005","article-title":"Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays","volume":"83","author":"Sonneveld","year":"2005","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.steroids.2011.02.043_bib0090","first-page":"4192","article-title":"Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells","volume":"45","author":"Sheen","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.steroids.2011.02.043_bib0095","first-page":"139","article-title":"Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells","volume":"42","author":"Eckert","year":"1982","journal-title":"Cancer Res"},{"key":"10.1016\/j.steroids.2011.02.043_bib0100","first-page":"805","article-title":"Inhibition of dexamethasone-induced cytoskeletal changes in cultured human trabecular meshwork cells by tetrahydrocortisol","volume":"37","author":"Clark","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.steroids.2011.02.043_bib0105","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1210\/endo-104-4-1007","article-title":"Androgen receptor assay with [3H] methyltrienolone (R1881) in the presence of progesterone receptor","volume":"104","author":"Zava","year":"1979","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2011.02.043_bib0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/14756360109162354","article-title":"Stable expression of human 5alpha-reductase isoenzymes type 1 and type 2 in HEK293 cells to identify dual and selective inhibitors","volume":"16","author":"Reichert","year":"2001","journal-title":"J Enzyme Inhib"},{"key":"10.1016\/j.steroids.2011.02.043_bib0115","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.steroids.2011.02.043_bib0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1677\/jme.1.01853","article-title":"Androgen metabolism via 17b-hydroxysteroid dehydrogenase type 3 in mammalian and non-mammalian vertebrates: comparison of the human and the zebrafish enzyme","volume":"35","author":"Mindnich","year":"2005","journal-title":"J Mol Endocrinol"},{"issue":"3a","key":"10.1016\/j.steroids.2011.02.043_bib0125","first-page":"1433","article-title":"Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity","volume":"24","author":"Chetrite","year":"2004","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.steroids.2011.02.043_bib0130","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.maturitas.2009.11.006","article-title":"Breast cancer and steroid metabolizing enzymes: the role of progestogens","volume":"65","author":"Pasqualini","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.steroids.2011.02.043_bib0135","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1530\/acta.0.0780574","article-title":"Progesterone-binding proteins: in vitro binding and biological activity of different steroidal ligands","volume":"78","author":"Kontula","year":"1975","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.steroids.2011.02.043_bib0140","first-page":"45","article-title":"Animal studies on the endocrinological profile of dienogest, a novel synthetic steroid","volume":"23","author":"Katsuki","year":"1997","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.steroids.2011.02.043_bib0145","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tox.2005.12.002","article-title":"Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context","volume":"220","author":"Simon","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.steroids.2011.02.043_bib0150","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/bi961775g","article-title":"Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor","volume":"36","author":"Doesburg","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.steroids.2011.02.043_bib0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/abio.2001.5352","article-title":"Development of an androgen reporter gene assay (ar-lux) utilizing a human cell line with an endogenously regulated androgen receptor","volume":"298","author":"Blankvoort","year":"2001","journal-title":"Anal Biochem"},{"key":"10.1016\/j.steroids.2011.02.043_bib0160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2011.02.043_bib0165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/taap.1998.8598","article-title":"Rapid and sensitive reporter gene assays for detection of antiandrogenic and estrogenic effects of environmental chemicals","volume":"155","author":"Vinggaard","year":"1999","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.steroids.2011.02.043_bib0170","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/me.13.3.440","article-title":"Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone","volume":"13","author":"Kemppainen","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.steroids.2011.02.043_bib0175","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.steroids.2007.10.003","article-title":"Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile","volume":"73","author":"Sasagawa","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2011.02.043_bib0180","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jsbmb.2005.07.009","article-title":"A comparative molecular modeling study of dydrogesterone with other progestational agents through theoretical calculations and nuclear magnetic resonance spectroscopy","volume":"98","author":"Colombo","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2011.02.043_bib0185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/09513590009167685","article-title":"Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro","volume":"14","author":"Rabe","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.steroids.2011.02.043_bib0190","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.fertnstert.2008.02.012","article-title":"Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin","volume":"89","author":"The Practice Committee of the American Society for Reproductive Medicine","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2011.02.043_bib0195","unstructured":"Hubbard WK. Proposed Rules. FR Document. Federal Register 1999;64:99-9146"},{"key":"10.1016\/j.steroids.2011.02.043_bib0200","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0009-2797(02)00206-5","article-title":"Selective and potent inhibitors of human 20\u03b1-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone","volume":"143-144","author":"Higaki","year":"2003","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.steroids.2011.02.043_bib0205","unstructured":"http:\/\/www.medicines.ie\/medicine\/5163\/SPC\/Duphaston, December 17 2010."},{"key":"10.1016\/j.steroids.2011.02.043_bib0210","doi-asserted-by":"crossref","unstructured":"Sata F, Kurahashi N, Ban S, Moriya K, Tanaka KD, Ishizuka M, et al. Genetic polymorphisms of 17beta-hydroxysteroid dehydrogenase type 3 and the risk of hypospadias. J Sex Med. 2010 Jan 6. [Epub ahead of print].","DOI":"10.1111\/j.1743-6109.2009.01641.x"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X11000833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X11000833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T23:58:13Z","timestamp":1560038293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X11000833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0039128X11000833"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2011.02.043","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}